Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group.
Affiliates of Bain Capital and Hellman & Friedman struck a deal to buy the health IT company from its current private equity owners, Veritas Capital and an affiliate of activist investor Elliott Management. The two took the company private through a takeover bid in 2019.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
The deal leaves Bain Capital with a minority stake in the company and values Waystar at $2.7 billion.
Earlier this year, Bloomberg News reported that Bain Capital was considering a sale of Waystar with Oracle and Visa named as two potential acquirers.
Cerevel will take on several clinical and preclinical candidates from Pfizer, which divested from neuroscience this year and will take a 25 percent stake in the new company.
Pierotti said the new funding will be used to bolster the company's sales and marketing team.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Washington-based Physio-Control will be integrated into Stryker’s emergency medical systems portfolio.
REACH Air Medical Services(Opens in a new window), part of the nation’s largest air medical transport network and Bain Capital(Opens in a new window)-backed AirMedCare,(Opens in a new window) is acquiring Oregon-based Emergency Airlift, giving the Northern California company broader, ahem, reach, into the Pacific Northwest.Terms of the deal were not disclosed. The acquisition will […]
(Opens in a new window)Bain Capital Ventures(Opens in a new window), a wing of the Boston private equity firm cofounded by Mitt Romney(Opens in a new window), has closed a new $600 million fund(Opens in a new window) to invest in business, Internet and healthcare companies.This is Bain Capital Ventures’ fifth fund and its largest […]
Five years after it first announced the desire to sell its emergency medical response business, Physio-Control, Medtronic (Opens in a new window)(NYSE:MDT(Opens in a new window)) has found a buyer in Bain Capital Ventures(Opens in a new window).The private equity firm will pay $487 million in cash to buy back ownership of the Redman, Washington-based […]
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
(Opens in a new window)Precision Therapeutics Inc.(Opens in a new window) has raised $34 million in equity and options to further develop a test that helps identify an individual’s best chemotherapy options, according to a filing(Opens in a new window) with the Securities and Exchange Commission.The company’s ChemoFX(Opens in a new window) drug marker tests […]
Bain Capital Ventures, which has invested in Midwestern health care start-ups, has raised a $525 million fund, its first since 2007.
Contract drug development organization Ricerca Biosciences LLC has agreed to acquire the discovery and preclinical business of MDS Pharma Services for $35 million less working capital and cap-ex reserve.